TY  -  JOUR
AU  -  Attilia, Fabio
AU  -  Perciballi, Roberta
AU  -  Rotondo, Claudia
AU  -  Capriglione, Ida
AU  -  Iannuzzi, Silvia
AU  -  Attilia, Maria Luisa
AU  -  Vitali, Mario
AU  -  Alessandrini, Giovanni
AU  -  Scamporrino, Maria Concetta Marcella
AU  -  Fiore, Marco
AU  -  Ceccanti, Mauro
AU  -  Interdisciplinary Study Group CRARL - 
SITAC - SIPaD - SITD - SIPDip
T1  -  Pharmacological treatment of alcohol use disorder. Scientific evidence
PY  -  2018
Y1  -  2018-05-01
DO  -  10.1708/2925.29414
JO  -  Rivista di Psichiatria
JA  -  Riv Psichiatr
VL  -  53
IS  -  3
SP  -  123
EP  -  127
PB  -  Il Pensiero Scientifico Editore
SN  -  2038-2502
Y2  -  2026/05/12
UR  -  http://dx.doi.org/10.1708/2925.29414
N2  -  SUMMARY. Pharmacological treatment of alcohol use disorder represents an essential core of the therapeutic project in a multidisciplinary approach. While non-drug treatment is evolving, from a medical perspective few pharmacotherapies are available; in particular acamprosate, naltrexone and more recently nalmefene among anticraving drugs, disulfiram as an antidipsotropic medication. New studies are focusing on off-label drugs. Moreover, scientific evidence has to support any therapeutic indication which should be tailored on patient needs and comorbidity by considering the individual bio-psycho-social profile. Follow-up is essential in order to assess patient compliance to treatment and monitoring outcomes.
ER  -